Literature DB >> 17686194

Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984-2005.

J A Crump1, P K Ram, S K Gupta, M A Miller, E D Mintz.   

Abstract

There are only 10 contemporary, population-based studies of typhoid fever that evaluate disease incidence using blood culture for confirmation of cases. Reported incidence ranged from 13 to 976/100 000 persons per year. These studies are likely to have been done preferentially in high- incidence sites which makes generalization of data difficult. Only five of these studies reported mortality. Of these the median (range) mortality was 0% (0-1.8%). Since study conditions usually involved enhanced clinical management of patients and the studies were not designed to evaluate mortality as an outcome, their usefulness for generalizing case-fatality rates is uncertain. No contemporary population-based studies reported rates of complications. Hospital-based typhoid fever studies reported median (range) complication rates of 2.8% (0.6-4.9%) for intestinal perforation and case-fatality rates of 2.0% (0-14.8%). Rates of complications other than intestinal perforation were not reported in contemporary hospital-based studies. Hospital-based studies capture information on the most severe illnesses among persons who have access to health-care services limiting their generalizability. Only two studies have informed the current understanding of typhoid fever age distribution curves. Extrapolation from population-based studies suggests that most typhoid fever occurs among young children in Asia. To reduce gaps in the current understanding of typhoid fever incidence, complications, and case-fatality rate, large population-based studies using blood culture confirmation of cases are needed in representative sites, especially in low and medium human development index countries outside Asia.

Entities:  

Mesh:

Year:  2007        PMID: 17686194      PMCID: PMC2870843          DOI: 10.1017/S0950268807009338

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  80 in total

1.  Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.

Authors:  M M Levine; C Ferreccio; P Abrego; O S Martin; E Ortiz; S Cryz
Journal:  Vaccine       Date:  1999-10-01       Impact factor: 3.641

2.  Multidrug resistant typhoid fever: study of an outbreak in Calcutta.

Authors:  R K Arora; A Gupta; N M Joshi; V K Kataria; P Lall; A C Anand
Journal:  Indian Pediatr       Date:  1992-01       Impact factor: 1.411

3.  Community-acquired septicaemia in southern Viet Nam: the importance of multidrug-resistant Salmonella typhi.

Authors:  N T Hoa; T S Diep; J Wain; C M Parry; T T Hien; M D Smith; A L Walsh; N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Sep-Oct       Impact factor: 2.184

4.  Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization.

Authors:  K P Klugman; H J Koornhof; J B Robbins; N N Le Cam
Journal:  Vaccine       Date:  1996-04       Impact factor: 3.641

5.  Typhoid fever in children: experience in King Chulalongkorn Memorial Hospital.

Authors:  Jurai Wongsawat; Chitsanu Pancharoen; Usa Thisyakorn
Journal:  J Med Assoc Thai       Date:  2002-12

6.  A controlled field trial and laboratory study of five typhoid vaccines in the USSR.

Authors:  L B Hejfec; L V Salmin; M Z Lejtman; M L Kuz'minova; A V Vasil'eva; L A Levina; T G Bencianova; E A Pavlova; A A Antonova
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

7.  Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.

Authors:  K P Klugman; I T Gilbertson; H J Koornhof; J B Robbins; R Schneerson; D Schulz; M Cadoz; J Armand
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

Review 8.  Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infection.

Authors:  David B Huang; Herbert L DuPont
Journal:  Lancet Infect Dis       Date:  2005-06       Impact factor: 25.071

9.  Quantitation of bacteria in bone marrow from patients with typhoid fever: relationship between counts and clinical features.

Authors:  J Wain; V B Pham; V Ha; N M Nguyen; S D To; A L Walsh; C M Parry; R P Hasserjian; V A HoHo; T H Tran; J Farrar; N J White; N P Day
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

10.  The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam.

Authors:  F Y Lin; A H Vo; V B Phan; T T Nguyen; D Bryla; C T Tran; B K Ha; D T Dang; J B Robbins
Journal:  Am J Trop Med Hyg       Date:  2000-05       Impact factor: 2.345

View more
  40 in total

1.  Global epidemiology of infections due to Shigella, Salmonella serotype Typhi, and enterotoxigenic Escherichia coli.

Authors:  M A Miller; J Sentz; M A Rabaa; E D Mintz
Journal:  Epidemiol Infect       Date:  2008-04       Impact factor: 2.451

Review 2.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 3.  Vaccination for typhoid fever in sub-Saharan Africa.

Authors:  Rachel B Slayton; Kashmira A Date; Eric D Mintz
Journal:  Hum Vaccin Immunother       Date:  2013-04-01       Impact factor: 3.452

Review 4.  Now you see me, now you don't: the interaction of Salmonella with innate immune receptors.

Authors:  A Marijke Keestra-Gounder; Renée M Tsolis; Andreas J Bäumler
Journal:  Nat Rev Microbiol       Date:  2015-03-09       Impact factor: 60.633

Review 5.  Genetic susceptibility to invasive Salmonella disease.

Authors:  James J Gilchrist; Calman A MacLennan; Adrian V S Hill
Journal:  Nat Rev Immunol       Date:  2015-07       Impact factor: 53.106

6.  The expanding spectrum of disease due to salmonella: an international perspective.

Authors:  Laila Woc-Colburn; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

Review 7.  Global trends in typhoid and paratyphoid Fever.

Authors:  John A Crump; Eric D Mintz
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

8.  Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal.

Authors:  Anoop S Pulickal; Samir Gautam; Elizabeth A Clutterbuck; Stephen Thorson; Buddha Basynat; Neelam Adhikari; Katherine Makepeace; Sjoerd Rijpkema; Ray Borrow; Jeremy J Farrar; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2009-08-26

9.  Utilization and accessibility of healthcare on Pemba Island, Tanzania: implications for health outcomes and disease surveillance for typhoid fever.

Authors:  Linda M Kaljee; Alfred Pach; Kamala Thriemer; Benedikt Ley; Said M Ali; Mohamed Jiddawi; Mahesh Puri; Lorenz von Seidlein; Jacqueline Deen; Leon Ochiai; Thomas Wierzba; John Clemens
Journal:  Am J Trop Med Hyg       Date:  2012-12-03       Impact factor: 2.345

10.  Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options.

Authors:  R-J Hassing; W H F Goessens; D J Mevius; W van Pelt; J W Mouton; A Verbon; P J van Genderen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-23       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.